Prostate cancer early diagnosis: circulating microRNA pairs potentially beyond single microRNAs upon 1231 serum samples
暂无分享,去创建一个
[1] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[2] T. Ochiya,et al. Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer , 2019, Clinical Cancer Research.
[3] Jun Yang,et al. A panel of five circulating microRNAs as potential biomarkers for prostate cancer , 2012, The Prostate.
[4] P. Carroll,et al. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. , 2011, Cancer research.
[5] R. Murakami,et al. Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study , 2019, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[6] D. Ouyang,et al. Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5 , 2013, Autophagy.
[7] H. Nishi,et al. Profiling analysis of circulating microRNA expression in cervical cancer. , 2016, Molecular and clinical oncology.
[8] Andrew J Vickers,et al. Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen , 2014, BMC Medicine.
[9] Raffaele Palmirotta,et al. Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology , 2018, Therapeutic advances in medical oncology.
[10] Arun Z. Thomas,et al. Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study. , 2014, The British journal of general practice : the journal of the Royal College of General Practitioners.
[11] X. Liu,et al. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis. , 2017, European review for medical and pharmacological sciences.
[12] Tao Wang,et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. , 2015, European urology.
[13] K. D. Sørensen,et al. Profiling of circulating microRNAs for prostate cancer biomarker discovery , 2013, Drug Delivery and Translational Research.
[14] B. Helfand,et al. The Impact of Prostate Biopsy on Urinary Symptoms, Erectile Function, and Anxiety , 2012, Current Urology Reports.
[15] Artemis G. Hatzigeorgiou,et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions , 2017, Nucleic Acids Res..
[16] Anssi Auvinen,et al. Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). , 2012, European urology.
[17] J. Oesterling,et al. Prostate specific antigen: a decade of discovery--what we have learned and where we are going. , 1999, The Journal of urology.
[18] J. Mayo,et al. The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas? , 2018, International journal of cancer.
[19] K. Takayama,et al. Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling , 2019, Biomolecules.
[20] A. Nadal,et al. Polluted Pathways: Mechanisms of Metabolic Disruption by Endocrine Disrupting Chemicals , 2017, Current Environmental Health Reports.
[21] R. Hruban,et al. MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls , 2013, Clinical Cancer Research.
[22] A. Naccarati,et al. Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection , 2018, Carcinogenesis.
[23] Qin Xu,et al. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma , 2019, Theranostics.
[24] B. Dennis,et al. Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis , 2018, The Annals of Family Medicine.
[25] Rui Henrique,et al. Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction , 2019, Front. Oncol..
[26] C. Marian,et al. Circulatory miR-628-5p is downregulated in prostate cancer patients , 2014, Tumor Biology.
[27] Olga Tanaseichuk,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.
[28] Y. Toiyama,et al. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] G. Prins. Endocrine disruptors and prostate cancer risk. , 2008, Endocrine-related cancer.
[30] A. Yoshimura,et al. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types , 2018, Journal of Ovarian Research.
[31] S. Pan,et al. miR-1290 is a potential prognostic biomarker in non-small cell lung cancer. , 2015, Journal of thoracic disease.
[32] F. Rizzi,et al. Roles of Autophagy Induced by Natural Compounds in Prostate Cancer , 2015, BioMed research international.
[33] Jun Luo,et al. Alternative splicing in prostate cancer , 2018, Nature Reviews Clinical Oncology.
[34] J. Raman,et al. Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer , 2018, The Prostate.